首页> 外文期刊>BJU international >Prediction of outcomes after radical prostatectomy in patients diagnosed with prostate cancer of biopsy Gleason score >/= 8 via contemporary multi (>/= 12)-core prostate biopsy.
【24h】

Prediction of outcomes after radical prostatectomy in patients diagnosed with prostate cancer of biopsy Gleason score >/= 8 via contemporary multi (>/= 12)-core prostate biopsy.

机译:经当代多中心(> / = 12)前列腺活检诊断为活检前列腺癌的格里森评分> / = 8的患者,在进行前列腺癌根治术后的结果预测。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: * To investigate the outcome of patients who underwent radical prostatectomy (RP) for prostate cancer of biopsy Gleason score >/= 8 diagnosed via contemporary prostate biopsy. PATIENTS AND METHODS: * We reviewed records of 151 patients who underwent RP for prostate cancer of biopsy Gleason score >/= 8 detected via multi (>/= 12)-core prostate biopsy without any neoadjuvant or adjuvant treatment. * Preoperative predictors of pathologically organ-confined disease along with biochemical recurrence-free survival were analyzed via multivariate logistic regression and Cox proportional hazards model. RESULTS: * For 151 total subjects, 5-year estimated biochemical recurrence-free survival rate was 41.0%. Patients with pathologically organ-confined disease were observed to have much higher 5-year biochemical recurrence-free survival rate than those otherwise (72.1 vs 31.5%, P < 0.001). * Serum PSA level (P= 0.031) and maximum tumour length in a biopsy core (P= 0.005) were observed to be significant preoperative predictors of having pathologically organ-confined disease. * As for biochemical recurrence-free survival following RP, serum PSA (P= 0.023), biopsy Gleason score (P= 0.032), and percent of total tumour length in biopsy cores (P < 0.001) were observed be significant preoperative predictors on multivariate analysis. CONCLUSION: * Among contemporary patients with biopsy Gleason score >/= 8 who underwent RP alone, patients with pathologically organ-confined disease demonstrated significantly better biochemical outcome than others. Serum PSA level and maximum tumour length in a biopsy core, independent predictors of organ-confined disease, would be useful in the selection of candidates for RP among patients presenting with biopsy Gleason score >/= 8.
机译:目的:*研究经根治性前列腺切除术(RP)进行活检的前列腺癌患者的结局,通过现代前列腺活检诊断格里森评分> / = 8。病人和方法:*我们回顾了151例接受RP活检的前列腺癌患者的记录,通过多中心(> / = 12)前列腺活检发现格里森评分> / = 8,而未进行任何新辅助或辅助治疗。 *通过多元logistic回归和Cox比例风险模型分析了病理学上受器官限制的疾病的术前预测因素以及无生化复发的生存期。结果:*对于151名受试者,估计5年无生化复发的生存率为41.0%。观察到病理性器官受限疾病患者的5年生化无复发生存率比其他患者高得多(72.1对31.5%,P <0.001)。 *观察到血清PSA水平(P = 0.031)和活检核心的最大肿瘤长度(P = 0.005)是发生病理性器官受限疾病的重要术前预测指标。 *至于RP后的无生化复发生存率,血清PSA(P = 0.023),活检Gleason评分(P = 0.032)和活检核心占肿瘤总长度的百分比(P <0.001)被认为是多变量的重要术前预测指标分析。结论:*在Gleason评分≥/ = 8的当代活检患者中,仅接受RP的患者,病理学上受器官限制的疾病的生化结果显着优于其他患者。活检核心中的血清PSA水平和最大肿瘤长度是器官限定疾病的独立预测因子,在有活检Gleason评分> / = 8的患者中选择RP候选者将很有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号